Evaluation of respiratory chain failure in mitochondrial cardiomyopathy by assessments of 99mTc-MIBI washout and 123I-BMIPP/99mTc-MIBI mismatch.

[1]  Y. Iwashita,et al.  Expression of permeability-glycoprotein (P-gp) and uptake of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (99Tcm-MIBI) in malignant tumour of the head and neck. , 2005, Dento maxillo facial radiology.

[2]  J. Moretti,et al.  To use MIBI or not to use MIBI? That is the question when assessing tumour cells , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  M. Böhm,et al.  Expression and Localization of P-glycoprotein in Human Heart , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[4]  K. Fukuchi,et al.  Myocardial imaging with 123I-BMIPP in patients with congestive heart failure , 1999, International Journal of Cardiac Imaging.

[5]  H. Aotsuka,et al.  A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) , 1998, Heart.

[6]  Y. Yokota,et al.  Diabetes Mellitus and Cardiomyopathy , 1998 .

[7]  Y. Magata,et al.  Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Y. Takeishi,et al.  Iodine-123-BMIPP imaging in unstable angina: a guide for interventional strategy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  S. Dimauro,et al.  The mitochondrial A3243G mutation presenting as severe cardiomyopathy. , 1997, Journal of medical genetics.

[10]  E. Ricci,et al.  Maternally inherited cardiomyopathy: A new phenotype associated with the A to G at nt.3243 of mitochondrial DNA (MELAS mutation) , 1997, Muscle & nerve.

[11]  K. Wakabayashi,et al.  Quantitation of heteroplasmy of mitochondrial trnaLeu(UUR) gene using PCR‐SSCP , 1995, Muscle & nerve.

[12]  M. Miyata,et al.  Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. , 1995, Circulation.

[13]  T. Ozawa,et al.  Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. , 1994, American heart journal.

[14]  G. Attardi,et al.  Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles , 1994, Molecular and cellular biology.

[15]  B. Holman,et al.  Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  K. Kako,et al.  Effects of hydrogen peroxide and hypochlorite on membrane potential of mitochondria in situ in rat heart cells. , 1991, Canadian journal of physiology and pharmacology.

[17]  I. Nonaka,et al.  A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.

[18]  J. Kronauge,et al.  Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. , 1990, Circulation.

[19]  Y. Yonekura,et al.  Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  J. Kronauge,et al.  Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  I. Pastan,et al.  Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. , 1990, The Journal of biological chemistry.

[22]  Hiroshi Suzuki,et al.  Pleiotropic molecular defects in energy-transducing complexes in mitochondrial encephalomyopathy (MELAS) , 1989, Journal of the Neurological Sciences.

[23]  R. Sakuta,et al.  Vascular involvement in mitochondrial myopathy , 1989, Annals of neurology.

[24]  Y. Yonekura,et al.  [Basic studies on I-123-beta-methyl-p-iodophenylpentadecanoic acid (BMIPP) for myocardial functional diagnosis: effect of beta-oxidation inhibitor]. , 1988, Kaku igaku. The Japanese journal of nuclear medicine.

[25]  A. Harding,et al.  Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies , 1988, Nature.

[26]  R. Okada,et al.  Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. , 1988, Circulation.

[27]  C. Orlandi,et al.  Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention , 2005, European Journal of Nuclear Medicine.

[28]  S. Reske,et al.  Catabolism of 15-(p-lodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) by isolated rat hearts , 2004, European Journal of Nuclear Medicine.

[29]  J. Holden,et al.  β-Methyl-15-p-iodophenylpentadecanoic acid metabolism and kinetics in the isolated rat heart , 2004, European Journal of Nuclear Medicine.